Cost-effectiveness and budget impact analysis of facility-based screening and treatment of hepatitis C in Punjab state of India.

ABSTRACT:

Objective

Despite treatment availability, chronic hepatitis C virus (HCV) public health burden is rising in India due to lack of timely diagnosis. Therefore, we aim to assess incremental cost per quality-adjusted life year (QALY) for one-time universal screening followed by treatment of people infected with HCV as compared with a no screening policy in Punjab, India.

Study design

Decision tree integrated with Markov model was developed to simulate disease progression. A societal perspective and a 3% annual discount rate were considered to assess incremental cost per QALY gained. In addition, budgetary impact was also assessed with a payer's perspective and time horizon of 5 years.

Study setting

Screening services were assumed to be delivered as a facility-based interv

SUBMITTER: Chugh Y 

PROVIDER: S-EPMC7887370 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature